Literature DB >> 15009036

The American College of Radiology's BI-RADS 3 Classification in a Nationwide Screening Program: current assessment and comparison with earlier use.

Debra L Monticciolo1, Lee S Caplan.   

Abstract

The Breast Imaging Reporting and Data System allows radiologists to classify lesions as "probably benign-short interval follow-up suggested" (category 3). The purpose of this study is to evaluate the recent use of the category 3 designation in a national cancer detection program. We analyzed data from the National Breast and Cervical Cancer Early Detection Program, a nationwide collaboration between the Centers for Disease Control and Prevention (CDC) and local health agencies that provides cancer screening for low-income, uninsured women. The study population included all women at least 40 years old who had mammograms in the program through September 1999 (n = 826,424). Of the 826,424 mammograms, the percentage classified as category 3 in the initial phase (1991-1996, previously reported, n = 372,760) was 7.7%; of the most recent 453,664 mammograms (1996-1999), 6.0% were given this designation. During the same periods, the percentage of abnormal mammograms decreased from 2.6% to 2.1% and those needing "additional imaging" (category 0) increased from 5.0% to 6.9%. The percentage receiving a category 3, category 0, or abnormal designation decreased with increasing age for each classification. The percentage of category 3 mammograms varied by site from 1.1% to 12.2%. Overall the proportions of category 3 mammograms decreased over time, while requests for additional examinations increased. This suggests that patients were more likely than before to receive additional examinations prior to their final designation. The persistent wide variability in category 3 indicates further education and attention to the use of this category is warranted.

Entities:  

Mesh:

Year:  2004        PMID: 15009036     DOI: 10.1111/j.1075-122x.2004.21289.x

Source DB:  PubMed          Journal:  Breast J        ISSN: 1075-122X            Impact factor:   2.431


  6 in total

Review 1.  Applications and literature review of the BI-RADS classification.

Authors:  S Obenauer; K P Hermann; E Grabbe
Journal:  Eur Radiol       Date:  2005-01-26       Impact factor: 5.315

2.  Optimal Policies for Reducing Unnecessary Follow-up Mammography Exams in Breast Cancer Diagnosis.

Authors:  Oguzhan Alagoz; Jagpreet Chhatwal; Elizabeth S Burnside
Journal:  Decis Anal       Date:  2013-09

3.  Use of BI-RADS 3-probably benign category in the American College of Radiology Imaging Network Digital Mammographic Imaging Screening Trial.

Authors:  Janet K Baum; Lucy G Hanna; Suddhasatta Acharyya; Mary C Mahoney; Emily F Conant; Lawrence W Bassett; Etta D Pisano
Journal:  Radiology       Date:  2011-04-18       Impact factor: 11.105

4.  Recommendation for short-interval follow-up examinations after a probably benign assessment: is clinical practice consistent with BI-RADS guidance?

Authors:  Erin J Aiello Bowles; Edward A Sickles; Diana L Miglioretti; Patricia A Carney; Joann G Elmore
Journal:  AJR Am J Roentgenol       Date:  2010-04       Impact factor: 3.959

5.  Comparison between breast MRI and contrast-enhanced spectral mammography.

Authors:  Elżbieta Łuczyńska; Sylwia Heinze-Paluchowska; Edward Hendrick; Sonia Dyczek; Janusz Ryś; Krzysztof Herman; Paweł Blecharz; Jerzy Jakubowicz
Journal:  Med Sci Monit       Date:  2015-05-12

6.  Breast effects of oral, combined 17β-estradiol, and progesterone capsules in menopausal women: a randomized controlled trial.

Authors:  James H Liu; Denise R Black; Lisa Larkin; Shelli Graham; Brian Bernick; Sebastian Mirkin
Journal:  Menopause       Date:  2020-12       Impact factor: 3.310

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.